Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald Lieberman

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
American Journal of Therapeutics|June 28, 2013
Progress in the treatment of peripheral T-cell lymphomas: an orphan no moreRonald Lieberman
World Journal of Urology|April 19, 2003
Evolving strategies for prostate cancer chemoprevention trialsRonald Lieberman
American Journal of Therapeutics|March 8, 2013
The androgen receptor, androgen synthesis, and new designer antiandrogens for metastatic castration-resistant prostate cancer: teaching old dogs new tricksRonald Lieberman
Cancer Metastasis Reviews|January 29, 2003
Chemoprevention of prostate cancer: current status and future directionsRonald Lieberman
American Journal of Therapeutics|October 16, 2009
Personalized medicine enters the US marketplace: KRAS, anti-EGFR monoclonal antibodies, and colon cancerRonald Lieberman
American Journal of Therapeutics|September 27, 2012
Food and Drug Administration approval of cetuximab and a new KRAS genetic test for metastatic colorectal cancer: major advance but just the tip of the biomarker icebergRonald Lieberman
American Journal of Therapeutics|November 16, 2004
Evidence-based medical perspectives: the evolving role of PSA for early detection, monitoring of treatment response, and as a surrogate end point of efficacy for interventions in men with different clinical risk states for the prevention and progression of prostate cancerRonald Lieberman
Archives of Physical Medicine and Rehabilitation|November 5, 2003
Fluoroscopically guided interlaminar cervical epidural injectionsRonald Lieberman, Paul Dreyfuss, Ray Baker
Oncology (Williston Park, N.Y.)|September 12, 2003
Clinical trials referral resource. Current NCI-sponsored clinical trials in prostate cancer: prevention, treatment, supportive care, and imagingAlison Martin, Ronald Lieberman, Howard Parnes, et al.
The Journal of Urology|January 10, 2004
Prostate cancer chemoprevention agent development: the National Cancer Institute, Division of Cancer Prevention portfolioHoward L Parnes, Margaret G House, Jacob Kagan, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
American Journal of Therapeutics|June 28, 2013
Progress in the treatment of peripheral T-cell lymphomas: an orphan no moreRonald Lieberman
World Journal of Urology|April 19, 2003
Evolving strategies for prostate cancer chemoprevention trialsRonald Lieberman
American Journal of Therapeutics|March 8, 2013
The androgen receptor, androgen synthesis, and new designer antiandrogens for metastatic castration-resistant prostate cancer: teaching old dogs new tricksRonald Lieberman
Cancer Metastasis Reviews|January 29, 2003
Chemoprevention of prostate cancer: current status and future directionsRonald Lieberman
American Journal of Therapeutics|October 16, 2009
Personalized medicine enters the US marketplace: KRAS, anti-EGFR monoclonal antibodies, and colon cancerRonald Lieberman
American Journal of Therapeutics|September 27, 2012
Food and Drug Administration approval of cetuximab and a new KRAS genetic test for metastatic colorectal cancer: major advance but just the tip of the biomarker icebergRonald Lieberman
American Journal of Therapeutics|November 16, 2004
Evidence-based medical perspectives: the evolving role of PSA for early detection, monitoring of treatment response, and as a surrogate end point of efficacy for interventions in men with different clinical risk states for the prevention and progression of prostate cancerRonald Lieberman
Archives of Physical Medicine and Rehabilitation|November 5, 2003
Fluoroscopically guided interlaminar cervical epidural injectionsRonald Lieberman, Paul Dreyfuss, Ray Baker
Oncology (Williston Park, N.Y.)|September 12, 2003
Clinical trials referral resource. Current NCI-sponsored clinical trials in prostate cancer: prevention, treatment, supportive care, and imagingAlison Martin, Ronald Lieberman, Howard Parnes, et al.
The Journal of Urology|January 10, 2004
Prostate cancer chemoprevention agent development: the National Cancer Institute, Division of Cancer Prevention portfolioHoward L Parnes, Margaret G House, Jacob Kagan, et al.
Pageof 3